Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
Radiofrequency Ablation and Bone AugmentationThis pilot study will try to demonstrate metabolic changes in spine lesions treated by Augmentation and Ablation, according to existing standards of practice. Our purpose is to show the efficacy of a new radiofrequency ablation (RFA) in combination with augmentation, using a percutaneous ablation device (Osteocool-Medtronic) in the treatment of secondary vertebral bone tumor, avoiding concurrent bias related to other treatments of the disease. Cancer À vérifier À vérifier Greece À vérifier
Radiofrequency Ablation and Bone AugmentationThis pilot study will try to demonstrate metabolic changes in spine lesions treated by Augmentation and Ablation, according to existing standards of practice. Our purpose is to show the efficacy of a new radiofrequency ablation (RFA) in combination with augmentation, using a percutaneous ablation device (Osteocool-Medtronic) in the treatment of secondary vertebral bone tumor, avoiding concurrent bias related to other treatments of the disease. Cancer À vérifier À vérifier Greece À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Radiofrequency Ablation and Bone Augmentation Cancer À vérifier NCT06716294 ABLASPINE — Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation RECRUITING

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.